Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway (Publication with Expression of Concern)

被引:228
作者
Pandey, Manoj K. [1 ]
Sung, Bokyung [1 ]
Ahn, Kwang Seok [1 ]
Kunnumakkara, Ajaikumar B. [1 ]
Chaturvedi, Madan M. [1 ]
Aggarwal, Bharat B. [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2007-03-079616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gambogic acid (GA), a xanthone derived from the resin of the Garcinia hanburyi, has been recently demonstrated to bind transferrin receptor and exhibit potential anticancer effects through a signaling mechanism that is not fully understood. Because of the critical role of NF-kappa B signaling pathway, we investigated the effects of GA on NF-kappa B-mediated cellular responses and NF-kappa B-regulated gene products in human leukemia cancer cells. Treatment of cells with GA enhanced apoptosis induced by tumor necrosis factor (TNF) and chemotherapeutic agents, inhibited the expression of gene products involved in antiapoptosis (lAP1 and IAP2, Bcl-2, Bcl-X-L, and TRAF1), proliferation (cyclin 1311 and c-Myc), invasion (COX-2 and MMP-9), and angiogenesis (VEGF), all of which are known to be regulated by NF-kappa B. GA suppressed NF-kappa B activation induced by various inflammatory agents and carcinogens and this, accompanied by the inhibition of TAKI/TAB1-mediated IKK activation, inhibited IKB alpha phosphorylation and degradation, suppressed p65 phosphorylation and nuclear translocation, and finally abrogated NF-kappa B-dependent reporter gene expression. The NF-kappa B activation induced by TNFR1, TRADD, TRAF2, NIK, TAK1/TAB1, and lKK beta was also inhibited. The effect of GA mediated through transferrin receptor as down-regulation of the receptor by RNA interference reversed its effects on NF-kappa B and apoptosis. Overall our results demonstrate that GA inhibits NF-kappa B signaling pathway and potentiates apoptosis through its interaction with the transferrin receptor.
引用
收藏
页码:3517 / 3525
页数:9
相关论文
共 57 条
[1]   From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer [J].
Aggarwal, BB ;
Ichikawa, H ;
Garodia, P ;
Weerasinghe, P ;
Sethi, G ;
Bhatt, ID ;
Pandey, MK ;
Shishodia, S ;
Nair, MG .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (01) :87-118
[2]   Nuclear factor-κ-B:: The enemy within [J].
Aggarwal, BB .
CANCER CELL, 2004, 6 (03) :203-208
[3]  
Akiyama M, 2003, CANCER RES, V63, P18
[4]   Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα:: correlation with induction of cyclooxygenase-2 [J].
Anto, RJ ;
Mukhopadhyay, A ;
Shishodia, S ;
Gairola, CG ;
Aggarwal, BB .
CARCINOGENESIS, 2002, 23 (09) :1511-1518
[5]   Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis [J].
Bharti, AC ;
Shishodia, S ;
Reuben, JM ;
Weber, D ;
Alexanian, R ;
Raj-Vadhan, S ;
Estrov, Z ;
Talpaz, M ;
Aggarwal, BB .
BLOOD, 2004, 103 (08) :3175-3184
[6]   TAK1 is recruited to the tumor necrosis factor-α (TNF-α) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-κB activation [J].
Blonska, M ;
Shambharkar, PB ;
Kobayashi, M ;
Zhang, DY ;
Sakurai, H ;
Su, B ;
Lin, X .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :43056-43063
[7]   Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB [J].
Campbell, KJ ;
Rocha, S ;
Perkins, ND .
MOLECULAR CELL, 2004, 13 (06) :853-865
[8]   Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer [J].
Catz, SD ;
Johnson, JL .
ONCOGENE, 2001, 20 (50) :7342-7351
[9]  
Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585
[10]   Genomic organization of human and mouse genes for vascular endothelial growth factor C [J].
Chilov, D ;
Kukk, E ;
Taira, S ;
Jeltsch, M ;
Kaukonen, J ;
Palotie, A ;
Joukov, V ;
Alitalo, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25176-25183